Axon Enterprise stock heads into the open after a 9.8% drop on note offering

Axon Enterprise stock closed at USD 442.08 on the Nasdaq on September 16, 2026, down 9.8% from the prior session after the company announced a USD 1 billion zero-coupon convertible senior notes offering maturing in 2031. The shares ended the day about 43% below their 52-week high of USD 777.58, while the S&P 500 slipped around 0.4% on the same session.

September 16, 2026 in numbers

Axon Enterprise Inc. (ISIN US05464C1018, Nasdaq: AXON) saw its stock fall 9.8% on September 16, 2026, closing at roughly USD 442 on the Nasdaq after the company unveiled plans to raise USD 1 billion through 0% convertible senior notes due 2031, accompanied by capped call transactions designed to limit dilution for existing shareholders, according to GuruFocus. The move followed Axon’s earlier disclosure that the USD 1 billion notes would carry a 0% coupon and be sold as convertible senior notes, a structure that the market interpreted as a sign that recent growth has not yet translated into sufficient self-funding cash flow, as Trefis reported on September 16, 2026. That day the shares traded well below their 52-week peak of USD 777.58, leaving the stock roughly 43% under that high, and closed at a level that GuruFocus described as about 32.1% below its intrinsic GF Value estimate of USD 650.74, implying significant undervaluation at the end of the session per GuruFocus. In the same trading session, broader market conditions were also weak, with the S&P 500 index declining by about 0.4%, while sector peers such as Motorola Solutions and Cadre recorded losses of 1.3% and 3.4% respectively, underscoring that Axon’s near-10% drop significantly exceeded the broader market’s move on September 16, 2026, according to Trefis.

Capital raise and data to watch today

Today, September 17, 2026, attention around Axon Enterprise centers on the progress of the USD 1 billion 0% convertible senior notes offering, which is expected to close on September 18, 2026 subject to customary conditions, a financing step that investors monitor for its impact on Axon’s balance sheet and future dilution profile as highlighted by GuruFocus. The notes carry a conversion price near USD 652.06 per share and are paired with capped call transactions with a cap price around USD 1,049.94, parameters that frame how much potential equity dilution future conversions might trigger, according to GuruFocus. Beyond the capital raise, investors today also have an eye on broader market risk sentiment after the recent pullback in major US equity indices, with Axon’s shares positioned well below their GF Value and 52-week high as they head into the next Nasdaq session.